100 related articles for article (PubMed ID: 19913079)
1. Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
van Duursen MB; Nijmeijer SM; Ruchirawat S; van den Berg M
Toxicol Lett; 2010 Feb; 192(3):271-7. PubMed ID: 19913079
[TBL] [Abstract][Full Text] [Related]
2. Resorcylic acid lactone L-783,277 inhibits the growth of the human adrenal cancer cell line H295R in vitro.
Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Altmann KH; Hofmann T; Stepien H
Int J Immunopathol Pharmacol; 2009; 22(4):889-95. PubMed ID: 20074452
[TBL] [Abstract][Full Text] [Related]
3. Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
Sanderson T; Renaud M; Scholten D; Nijmeijer S; van den Berg M; Cowell S; Guns E; Nelson C; Mutarapat T; Ruchirawat S
Eur J Pharmacol; 2008 Sep; 593(1-3):92-8. PubMed ID: 18639541
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: a novel mechanism of action?
Cantón RF; Sanderson JT; Nijmeijer S; Bergman A; Letcher RJ; van den Berg M
Toxicol Appl Pharmacol; 2006 Oct; 216(2):274-81. PubMed ID: 16828825
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of 3beta-hydroxysteroid dehydrogenase type II and 17alpha-hydroxylase/lyase P450 in human adrenocortical carcinoma cells by epidermal growth factor and basic fibroblast growth factor.
Doi J; Takemori H; Ohta M; Nonaka Y; Okamoto M
J Endocrinol; 2001 Jan; 168(1):87-94. PubMed ID: 11139773
[TBL] [Abstract][Full Text] [Related]
6. Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX.
Sangjun S; de Jong E; Nijmeijer S; Mutarapat T; Ruchirawat S; van den Berg M; van Duursen MB
Toxicol Lett; 2009 Apr; 186(2):115-22. PubMed ID: 19429232
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Endocr Res; 2009; 34(3):68-79. PubMed ID: 19701832
[TBL] [Abstract][Full Text] [Related]
8. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
9. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.
McCann SE; Moysich KB; Freudenheim JL; Ambrosone CB; Shields PG
J Nutr; 2002 Oct; 132(10):3036-41. PubMed ID: 12368392
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells.
Hu X; Washington S; Verderame MF; Manni A
Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined lignan phytoestrogen and melatonin treatment on secretion of steroid hormones by adrenal carcinoma cells.
Fecteau KA; Eiler H; Oliver JW
Am J Vet Res; 2011 May; 72(5):675-80. PubMed ID: 21529220
[TBL] [Abstract][Full Text] [Related]
12. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
[TBL] [Abstract][Full Text] [Related]
13. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.
Piller R; Verla-Tebit E; Wang-Gohrke S; Linseisen J; Chang-Claude J
J Nutr; 2006 Jun; 136(6):1596-603. PubMed ID: 16702327
[TBL] [Abstract][Full Text] [Related]
14. The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay.
Roelofs MJ; Piersma AH; van den Berg M; van Duursen MB
Toxicol Appl Pharmacol; 2013 May; 268(3):309-17. PubMed ID: 23415678
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells.
Cosentino M; Marino F; Ferrari M; Rasini E; Bombelli R; Luini A; Legnaro M; Delle Canne MG; Luzzani M; Crema F; Paracchini S; Lecchini S
Pharmacol Res; 2007 Aug; 56(2):140-7. PubMed ID: 17572100
[TBL] [Abstract][Full Text] [Related]
16. Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro.
McCann MJ; Gill CI; Linton T; Berrar D; McGlynn H; Rowland IR
Mol Nutr Food Res; 2008 May; 52(5):567-80. PubMed ID: 18398867
[TBL] [Abstract][Full Text] [Related]
17. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.
Carreau C; Flouriot G; Bennetau-Pelissero C; Potier M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):176-85. PubMed ID: 18457947
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer.
Xiong XY; Hu XJ; Li Y; Liu CM
Nutr Cancer; 2015; 67(8):1324-32. PubMed ID: 26473769
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20.
Abarzua S; Serikawa T; Szewczyk M; Richter DU; Piechulla B; Briese V
Arch Gynecol Obstet; 2012 Apr; 285(4):1145-51. PubMed ID: 22037685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
